Dark

Check out our Dark Pool Levels

BLRZF
BLACKHAWK GROWTH CRP
stock OTC

Inactive

Oct 15, 2021

0.4700USD+25.400%(+0.0952)520

Pre-market

0.00USD-100.000%(-0.37)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 21, 2022

11:32PM EST Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder Benzinga

Jan 8, 2022

11:01PM EST Blackhawk's MindBio Therapeutics to Develop Proprietary Drug Delivery Technology for Psychedelic Medicines Benzinga

Dec 17, 2021

11:01PM EST Blackhawk Growth Fully Funds Phase II Clinical Trials in Psychedelics and Begins Development of Digital Mental Health Treatments Benzinga

Nov 30, 2021

04:17PM EST Blackhawk Growth Files Quarter Ended September 30, 2021 Financials and Reports Increase in Value of its Portfolio by 165% Quarter Over Quarter Benzinga

Nov 19, 2021

11:31PM EST Blackhawk Growth's MindBio Therapeutics Advances Microdosing Clinical Trial to 59 Patients Benzinga

Nov 15, 2021

10:26AM EST Blackhawk Growth's MindBio Therapeutics Completes Safety Milestone in its Phase 1 Clinical Trials Benzinga

Nov 3, 2021

09:11AM EDT Blackhawk Growth Files Fiscal Year Ended June 30, 2021 Financial Reports Benzinga

Oct 17, 2021

12:02AM EDT Blackhawk Growth's SAC Pharma Continues to Expand Product Line and Services Benzinga

Oct 9, 2021

12:31AM EDT Blackhawk Growth's MindBio Therapeutics Successfully Progressed to the Second Half of their Phase 1 Microdosing Clinical Trial Benzinga

Sep 28, 2021

12:21AM EDT Blackhawk's MindBio Therapeutics Utilizes Trip Pharma to Bring Microdosing Trials to North America Benzinga

Sep 21, 2021

02:32AM EDT Blackhawk Growth's MindBio Therapeutics Plans to Commercialize Intellectual Property Generated from the University of Auckland's Clinical Trial in Psychedelic Assisted Therapy in Advanced Stage Cancer Patients Benzinga

Sep 18, 2021

12:11AM EDT Blackhawk Growth's MindBio Therapeutics Opens World Class Facility for the Pharmaceutical Industry Benzinga

Sep 14, 2021

12:31AM EDT Blackhawk Growth's SAC Pharma Announces Record August Revenue of CDN$460,000 and Includes Operational Update Benzinga

Sep 12, 2021

12:11AM EDT Blackhawk Growth Subsidiary, MindBio Therapeutics, Accelerates Phase 1 & Phase 2 Microdosing Clinical Trials Benzinga

Sep 5, 2021

12:21AM EDT Blackhawk Growth to Complete Investment in Psychedelic and Wellness Company MindBio Therapeutics Pty Ltd. Benzinga

Aug 24, 2021

02:11AM EDT Blackhawk Growth's Subsidiary Spaced Food Completes Successful First Run of Cannabis Infused Sorbet and Adds Three New Products Benzinga

Aug 18, 2021

12:01AM EDT Blackhawk Growth's Cannabis Infused Edible Brand Spaced Food Hires Branding and Marketing Firm for Product Launch Benzinga

Jul 26, 2021

12:24AM EDT Blackhawk Growth Establishes Annual Revenue Record Of $3,934,000 Benzinga

Jun 6, 2021

12:31AM EDT Blackhawk Growth Files Quarter Ended March 31, 2021 Financial Reports Benzinga

May 22, 2021

12:21AM EDT Blackhawk's Subsidiary Spaced Food Ramps Up Production of Cannabis Infused Edibles Benzinga

May 1, 2021

12:21AM EDT Blackhawk Growth Establishes Quarterly Revenue Record of $1,341,000 - an Increase of 58% From Previous Quarter Benzinga

Apr 20, 2021

12:31AM EDT Amended: Blackhawk Growth Enters Into Letter Of Intent To Acquire California-Based Licensed Distribution Center - Terp Wholesale, LLC Benzinga

Apr 13, 2021

02:01AM EDT MPX International Enters Into a Licensing Agreement with Blackhawk Growth Corporation for Innovative Edibles Benzinga

Apr 12, 2021

07:24PM EDT Blackhawk Growth's Cannabis Infused Spaced Food Signs Definitive Agreement; Receives Multiple Purchase Orders and Adds British Columbia Sales Benzinga

Share